Colonial Trust Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $160K | Buy |
5,706
+7
| +0.1% | +$186 | 0.01% | 219 |
|
|
2025
Q4 | $142K | Sell |
5,699
-844
| -13% | -$21.3K | 0.01% | 227 |
|
|
2025
Q3 | $167K | Sell |
6,543
-6,180
| -49% | -$153K | 0.01% | 213 |
|
|
2025
Q2 | $308K | Buy |
12,723
+2,463
| +24% | +$57.4K | 0.03% | 175 |
|
|
2025
Q1 | $260K | Sell |
10,260
-663
| -6% | -$17.3K | 0.02% | 181 |
|
|
2024
Q4 | $290K | Sell |
10,923
-19,072
| -64% | -$517K | 0.03% | 169 |
|
|
2024
Q3 | $868K | Buy |
29,995
+14,332
| +92% | +$418K | 0.08% | 121 |
|
|
2024
Q2 | $438K | Sell |
15,663
-2,764
| -15% | -$76.1K | 0.04% | 135 |
|
|
2024
Q1 | $511K | Sell |
18,427
-6,057
| -25% | -$168K | 0.05% | 133 |
|
|
2023
Q4 | $705K | Sell |
24,484
-7,708
| -24% | -$233K | 0.07% | 122 |
|
|
2023
Q3 | $1.07M | Sell |
32,192
-1,035
| -3% | -$36.6K | 0.12% | 108 |
|
|
2023
Q2 | $1.22M | Sell |
33,227
-2,571
| -7% | -$100K | 0.14% | 104 |
|
|
2023
Q1 | $1.46M | Buy |
35,798
+132
| +0.4% | +$5.7K | 0.17% | 97 |
|
|
2022
Q4 | $1.83M | Sell |
35,666
-394
| -1% | -$18.9K | 0.22% | 90 |
|
|
2022
Q3 | $1.58M | Buy |
36,060
+3,690
| +11% | +$179K | 0.21% | 92 |
|
|
2022
Q2 | $1.7M | Buy |
32,370
+107
| +0.3% | +$5.45K | 0.24% | 85 |
|
|
2022
Q1 | $1.67M | Sell |
32,263
-407
| -1% | -$21.1K | 0.2% | 91 |
|
|
2021
Q4 | $1.93M | Buy |
32,670
+1,122
| +4% | +$55.6K | 0.22% | 84 |
|
|
2021
Q3 | $1.36M | Buy |
31,548
+1,202
| +4% | +$53.2K | 0.17% | 95 |
|
|
2021
Q2 | $1.19M | Sell |
30,346
-5,398
| -15% | -$210K | 0.15% | 99 |
|
|
2021
Q1 | $1.29M | Sell |
35,744
-3,010
| -8% | -$107K | 0.17% | 92 |
|
|
2020
Q4 | $1.43M | Sell |
38,754
-1,995
| -5% | -$73.2K | 0.2% | 83 |
|
|
2020
Q3 | $1.42M | Buy |
40,749
+17,742
| +77% | +$622K | 0.22% | 80 |
|
|
2020
Q2 | $714K | Sell |
23,007
-1,316
| -5% | -$44.7K | 0.12% | 101 |
|
|
2020
Q1 | $753K | Sell |
24,323
-1,051
| -4% | -$35.8K | 0.16% | 90 |
|
|
2019
Q4 | $943K | Sell |
25,374
-563
| -2% | -$20.1K | 0.16% | 99 |
|
|
2019
Q3 | $884K | Sell |
25,937
-1,042
| -4% | -$37.9K | 0.16% | 99 |
|
|
2019
Q2 | $1.11M | Buy |
26,979
+1,051
| +4% | +$41.7K | 0.2% | 89 |
|
|
2019
Q1 | $1.04M | Buy |
25,928
+476
| +2% | +$19.1K | 0.2% | 90 |
|
|
2018
Q4 | $1.05M | Sell |
25,452
-1,390
| -5% | -$57.7K | 0.26% | 83 |
|
|
2018
Q3 | $1.12M | Buy |
26,842
+230
| +0.9% | +$8.85K | 0.21% | 95 |
|
|
2018
Q2 | $916K | Sell |
26,612
-1,084
| -4% | -$37K | 0.18% | 97 |
|
|
2018
Q1 | $933K | Sell |
27,696
-9,129
| -25% | -$314K | 0.19% | 100 |
|
|
2017
Q4 | $1.27M | Buy |
36,825
+9,432
| +34% | +$322K | 0.2% | 93 |
|
|
2017
Q3 | $928K | Sell |
27,393
-1,931
| -7% | -$62.1K | 0.2% | 97 |
|
|
2017
Q2 | $935K | Buy |
29,324
+11,503
| +65% | +$363K | 0.21% | 98 |
|
|
2017
Q1 | $559K | Sell |
17,821
-47,858
| -73% | -$1.51M | 0.17% | 97 |
|
|
2016
Q4 | $2.02M | Sell |
65,679
-512
| -0.8% | -$15.6K | 0.65% | 52 |
|
|
2016
Q3 | $2.13M | Sell |
66,191
-1,469
| -2% | -$49.1K | 0.67% | 50 |
|
|
2016
Q2 | $2.26M | Buy |
67,660
+824
| +1% | +$26.3K | 0.72% | 45 |
|
|
2016
Q1 | $1.88M | Buy |
66,836
+386
| +0.6% | +$11K | 0.61% | 54 |
|
|
2015
Q4 | $2.04M | Sell |
66,450
-1,000
| -1% | -$31.5K | 0.68% | 48 |
|
|
2015
Q3 | $2.01M | Buy |
67,450
+1,374
| +2% | +$44.1K | 0.68% | 52 |
|
|
2015
Q2 | $2.1M | Buy |
66,076
+30,221
| +84% | +$985K | 0.65% | 55 |
|
|
2015
Q1 | $1.18M | Buy |
35,855
+10,778
| +43% | +$343K | 0.36% | 76 |
|
|
2014
Q4 | $741K | Sell |
25,077
-637
| -2% | -$18.3K | 0.29% | 82 |
|
|
2014
Q3 | $721K | Buy |
25,714
+9,383
| +57% | +$263K | 0.22% | 89 |
|
|
2014
Q2 | $460K | Buy |
16,331
+5,745
| +54% | +$164K | 0.14% | 106 |
|
|
2014
Q1 | $323K | Buy |
10,586
+210
| +2% | +$6.26K | 0.1% | 114 |
|
|
2013
Q4 | $302K | Hold |
10,376
| – | – | 0.09% | 106 |
|
|
2013
Q3 | $283K | Hold |
10,376
| – | – | 0.1% | 102 |
|
|
2013
Q2 | $276K | Buy |
+10,376
| New | +$287K | 0.1% | 101 |
|
Other funds holding PFE
VCM
VPM
Colonial Trust Advisors's PFE Position: Q1 2026 in Review
Colonial Trust Advisors increased its Pfizer (PFE) stake by 0.12% in Q1 2026, buying an estimated $186 and bringing the position to 5,706 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #219.
Colonial Trust Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.26M in Q2 2016. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Colonial Trust Advisors held 5,706 shares of Pfizer worth $160K as of Q1 2026.
- Colonial Trust Advisors bought 7 Pfizer shares in Q1 2026, an estimated $186.
- Pfizer made up 0.01% of Colonial Trust Advisors's portfolio in Q1 2026, its #219 holding.
- Colonial Trust Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Colonial Trust Advisors's Pfizer position peaked at $2.26M in Q2 2016.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.